Clinical Trial Update: Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial assessing Cancer Macrobeads in treatment-resistant pancreatic and colorectal cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• Cancer Macrobeads (Cancer Macrobeads)

Snippet

Sponsor: The Rogosin Institute | Conditions: Pancreatic Adenocarcinoma Non-resectable, Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2021-04-23